RxDoctor Payments DataLook up a doctor →

Adam Schmuckler

Medical · Columbia, MDNPI 1902903990

Payments from drug & device makers

$17,081in general payments, 2019–2025

Across 512 payments — averaging $33.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rigel Pharmaceuticals, Inc.$3K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Johnson & Johnson$1K
  • Novartis$1K
  • AstraZeneca$1K
  • Pfizer$833
  • plus $8K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Rigel Pharmaceuticals, Inc.10$3,285
E.r. Squibb & Sons, L.L.C.25$1,345
Johnson & Johnson(2 entities)31$1,297
Novartis52$1,177
AstraZeneca(2 entities)37$1,036
Pfizer36$833
Daiichi Sankyo Inc.18$516
Genentech USA, Inc.20$450
Takeda Pharmaceuticals U.S.A., Inc.17$433
Merck18$414
Incyte Corporation16$383
Bayer14$379
GSK9$332
AbbVie13$308
Beigene USA, Inc.5$290
Amgen15$271
Lilly USA, LLC12$257
Bristol Myers Squibb7$253
Beone Medicines USA, Inc.6$244
Seagen Inc.10$225
Pharmaessentia USA Corporation7$214
Eisai Inc.9$212
Sanofi8$207
Sobi, Inc9$200
Exelixis Inc.7$183
AVEO Pharmaceuticals, Inc.7$178
Gilead(2 entities)7$172
Immunocore Limited5$158
ADC Therapeutics America, Inc.8$147
Regeneron Healthcare Solutions, Inc.6$137
Dendreon Pharmaceuticals LLC6$136
Mirati Therapeutics, Inc.5$109
Ipsen Biopharmaceuticals, Inc5$106
Pharmacosmos Therapeutics Inc.3$86
Azurity Pharmaceuticals, Inc.3$74
Array Biopharma Inc3$68
Astellas Pharma US Inc4$67
Syndax Pharmaceuticals, Inc.2$65
Taiho Oncology, Inc.2$63
Puma Biotechnology, Inc.3$63
Sumitomo Pharma America, Inc.3$57
Tersera Therapeutics LLC2$54
Deciphera Pharmaceuticals Inc.3$51
Legend Biotech USA Inc.2$51
EMD Serono, Inc.2$48
Morphosys, US Inc.2$41
Spectrum Pharmaceuticals Inc.2$40
Iovance Biotherapeutics, Inc.1$40
Alnylam Pharmaceuticals Inc.2$33
Pharmacyclics LLC, An Abbvie Company1$29
EUSA Pharma (US) LLC1$28
Corcept Therapeutics1$27
Global Blood Therapeutics, Inc.1$25
Myriad Genetic Laboratories, Inc.1$25
Myovant Sciences Inc.1$24
Accord Healthcare, Inc.1$24
Boehringer Ingelheim1$23
Blueprint Medicines Corporation1$20
Recordati_rare_diseases_inc.1$19
Kyowa Kirin, Inc.1$18

How this compares

$17,081 in reported general payments places this provider in the 95th percentile of 543 medical providers in Maryland.

See all medical providers in Maryland →

Medicare billing

Part B allowed, 2024
$9,874
Medicare patients
75
Services billed
82

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Columbia

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →